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Suppression of Urinary Voiding “on Demand”
by High-Frequency Stimulation of the S1
Sacral Nerve Root in Anesthetized Rats
Charly B.J. Brouillard, PhD; Jonathan J. Crook, PhD; Thelma A. Lovick, PhD
Objectives: High-frequency (kHz) stimulation of preganglionic pelvic nerve afferents can inhibit voiding in both anesthetized
and conscious rats. The afferents travel via the S1 sacral nerve root, which is easier to access than the distal pelvic nerve fibers
within the abdominal cavity. We therefore investigated whether voiding could be inhibited by high-frequency stimulation at
S1 and how this compared to distal pelvic nerve stimulation.
Methods: Urethane-anesthetized rats were instrumented to record bladder pressure and abdominal wall electromyogram and
to stimulate the distal preganglionic pelvic nerve bundle and S1 sacral root. Saline was infused continuously into the bladder
to evoke repeated voiding. Stimulation was initiated within 1–2 sec of the onset of the steep rise in bladder pressure signaling
an imminent void.
Results: In six rats, stimulation of the distal pelvic nerve bundle (1‑3 kHz sinusoidal waveform 1 mA, 60 sec) supressed
the occurrence of an imminent void. Voiding resumed within 70  13.0 sec (mean  SEM) of stopping stimulation. Stim-
ulation (using the same parameters) of the S1 root at the level of the sacral foramen suppressed voiding for the entire
stimulation period in three rats and deferred voiding for 35–56 sec (mean 44.0  3.2 sec) in the remaining three. Stimu-
lation at either site when the bladder was approximately half full, as estimated from previous intervoid intervals, had no
effect on voiding.
Conclusions: This preliminary study provides proof-of-concept for the sacral root as an accessible target for high-frequency
stimulation that may be developed as an “on demand” neuromodulation paradigm to suppress unwanted urinary voids.
Keywords: High-frequency stimulation, pelvic nerve, rat, sacral nerve, urinary voiding
Conflict of Interest: The authors reported no conflict of interest.
INTRODUCTION
Sacral neuromodulation is the most commonly used, clinically
effective intervention, for treating a number of urinary and
bowel dysfunctions that are refractory to conservative manage-
ment. Several recent evaluations (1–3) conclude that as experi-
ence grows, considerable levels of long-term therapeutic success
(>50% improvement in main symptoms/leakage episodes) and
improved quality of life can be expected in patients with urinary
urge incontinence and urgency frequency. Nonetheless, adverse
effects such as pain and the requirement for reintervention still
remain problematic (1).
Current sacral neuromodulation procedures typically use con-
tinuous, low-frequency stimulation in the region of 10‑15 Hz.
The precise mechanism(s) underlying the effectiveness of this
method is not understood completely, however, studies in
large animal models have demonstrated an increase in bladder
capacity (4,5). Although, this is certainly a major factor underly-
ing efficacy in some patients with overactive bladder, continu-
ous stimulation may not be optimal for all applications. For the
patient with urinary urge incontinence, for example, an attrac-
tive refinement would be conditional or “on demand” stimula-
tion (6,7). The ability to suppress unwanted voiding when urge
occurs, thereby buying time to move to a suitable and socially
acceptable environment to empty the bladder, would confer a
significant psychological advantage to the patient by restoring
autonomy over control of their bladder. It would also have
the additional benefit of increased device lifespan due to longer
battery life (although in-situ rechargeable devices may obviate
this need eventually).
With these provisos in mind, we developed an animal model in
which imminent voids can be suppressed on demand. In anesthe-
tized rats, initiating high-frequency (1‑3 kHz) stimulation of the
pelvic nerve at the onset of the bladder contraction signaling an
imminent void aborts the void and maintains urinary continence
during the stimulation period (8). The effect is rapid in onset,
reproducible, and readily reversible. Voids could be similarly sup-
pressed in chronically instrumented conscious rats without evok-
ing any sign of discomfort or other adverse side effects (9).
These studies provided proof-of-concept for high-frequency
stimulation of the pelvic nerve to control urinary continence “on
demand.” However, a limitation to the translational potential of
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pelvic nerve stimulation is the invasive surgery (laparotomy)
required to access the preganglionic pelvic nerve bundle. An
alternative approach would be to access the pelvic nerve fibers
outside the abdominal cavity as they approach the spinal cord. In
Wistar rats, most pelvic nerve afferents enter the cord in the S1
spinal root (10). We therefore carried out a preliminary study in
anesthetized rats to determine whether high-frequency stimula-
tion at the S1 spinal root could inhibit voiding, and whether the
effectiveness of stimulation at this site compares favorably with
stimulation of the distal preganglionic pelvic nerve bundle within
the abdominal cavity.
MATERIALS AND METHODS
Experiments were carried out under the U.K. Animals (Scientific
Procedures) Act 1986, project license PPL30/3200. Female Wistar
rats (245‑283 g) were anesthetized with urethane (0.7 mL/100 g
20% solution i.p.). Rectal temperature was maintained at 37C
using a thermostatically controlled heating blanket. With the ani-
mal supine, the left femoral artery and left femoral vein were can-
nulated in order to measure blood pressure and for intravenous
fluid replacement, respectively, as needed. A midline abdominal
incision was made to expose the bladder and a polythene cathe-
ter inserted into the bladder through the dome and secured in
place with 6.0 silk suture (8). The left pelvic nerve was then located
and a miniature bipolar cuff electrode (11) positioned on the pregan-
glionic nerve bundle just proximal to the pelvic ganglion. The func-
tional integrity of the nerve to bladder connection was confirmed by
stimulating the nerve at low frequency (10 Hz, 1 mA for 10 sec) and
observing a rise in bladder pressure, typically accompanied by a
small rise in blood pressure (8–17 mmHg) as reported previously (8).
The abdominal incision was then closed, and the bladder catheter
and leads from the electrode exteriorised via the flank. In three rats,
two needle electrodes, orientated rostro-caudally 10 mm apart, were
inserted into the external oblique muscle on right side approxi-
mately 1 cm lateral to the midline to measure electromyogram
(EMG). This enabled us to assess the contribution of the abdominal
musculature to voiding under anesthesia and to determine whether
stimulation of the pelvic nerve or S1 root evoked contraction of the
abdominal wall.
The preparation was then turned prone and a midline incision
made to expose the lumbar and sacral vertebrae. The paraverteb-
ral muscles were reflected and a clamp was applied to the L6 ver-
tebra to stabilize the spine. The S1 foramen was located on the
left side (Fig. 1) (12) and soft tissue cleared from the bone to
allow a bipolar silver wire electrode (inter-electrode distance
1 mm) to be positioned on the foramen. The tail was lifted so that
drops of fluid expelled from the urethra could be observed and
counted. Correct positioning of the electrode was confirmed by
repetitive twitching of the tail and perineal region evoked in
response to stimulation at 10 Hz. In contrast to the effects of
low-frequency stimulation of the pelvic nerve, no change in
blood pressure and only a minimal increase in bladder pressure
(0‑2 mmHg) were evoked by this procedure. Once the electrode
was positioned correctly, the exposed tissue was flooded with
warm liquid paraffin to prevent it drying and to prevent electri-
cal shorting between the electrode poles due to accumulation of
tissue fluid.
Once the surgery had been completed, the preparation was
left to stabilize for 30‑60 min. Saline was then infused into the
bladder at 6 mL h−1 using a syringe pump (PHD 2000, Harvard
Apparatus, Cambourne, UK). A T-piece in the line enabled simulta-
neous recording of bladder pressure. Physiological variables were cap-
tured using a Powerlab 16/35 data acquisition system (AD Instruments,
Oxford, UK) operating LabChart v8. Pelvic or sacral nerve stimulation
was delivered via a constant current stimulator (STMISOLA, Biopac Sys-
tem Inc., Goleta, CA, USA). A sinusoidal waveform (0.5‑10 kHz) was
used to deliver a charge balanced stimulus with an intensity of 1 or
2 mA. In a previous study, we had found these parameters to be opti-
mal for inhibiting voiding by stimulating the pelvic nerve (8). EMG
activity was amplified (5000x) and filtered 50‑5000 Hz using a Neuro-
log system (Digitimer Ltd, Welwyn Garden City, Hertfordshire, UK). All
values are given asmeans SEM.
RESULTS
Experiments were carried out on 13 rats. Repeated voiding in
response to continuous infusion of saline into the bladder was
established in six animals. A void was defined as a coordinated
contraction of the bladder accompanied by rapid expulsion of
several drops of liquid from the urethra. Table 1 shows the urody-
namic characteristics of voiding in these animals. During the fill-
ing phase bladder, pressure increased gradually until a threshold
was reached (15.8  0.27 mmHg), whereupon the pressure rose
sharply to reach a peak prior to expulsion of several drops of
urine from the urethra (Fig. 2a).
A low level of tonic activity was present on the abdominal
EMG signal during filling. In one animal phasic activity time-
locked to respiratory expiration was superimposed on the tonic
signal (13). When a void was imminent, there was a dramatic
increase in abdominal EMG activity when bladder pressure
reached 20.4  0.3 mmHg, that is, immediately prior to attain-
ing peak bladder pressure. The high level of activity was
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Figure 1. Location of stimulating electrodes on S1 foramen. Image of rat
spine reproduced from (12) with permission from Elsevier publisher. [Color fig-
ure can be viewed at wileyonlinelibrary.com]
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sustained for 4.37  0.19 sec during which time liquid was
expelled via the urethra (Fig. 2a). In one of the rats, this burst
of activity was preceded by an earlier (1.7  0.28 sec prior)
period of lower level abdominal EMG activity, which appeared
when bladder pressure reached 16.9  1.1 mmHg. In seven
rats, integrated voids failed to establish reliably. Intravesicular
pressure increased as saline was infused into the bladder and
then remained stable at a high level while fluid dripped from
the urethra at regular intervals (overflow). Because our experi-
mental protocol required stable physiological voiding over a
period of several hours in order to test the effects of sacral and
pelvic nerve stimulation, the seven rats that developed over-
flow incontinence were discarded.
Modulation of Voiding by Stimulation of the Pelvic Nerve and
S1 Sacral Root
Pelvic Nerve Stimulation
In each experiment, we first established that pelvic nerve stimu-
lation inhibited voiding, as described previously (8). In every
animal (6/6 rats), pelvic nerve stimulation was effective. Stimula-
tion at 1 mA was initially tested and if this proved ineffective, the
intensity was raised to 2 mA. Optimal effects were obtained using
stimulation frequencies of 1 or 3 kHz, 1–2 mA for 60 sec (Figs. 2b
and 3a). In 8/9 tests using optimal stimulation parameters, immi-
nent voiding was suppressed completely by stimulation initiating
within 1.0–2.4 sec (mean 1.44  0.21 sec) of the onset of the pre-
ceding sharp rise in bladder pressure. Continence was maintained
for the duration of the stimulus (Fig. 3a), and voiding resumed
70  13.0 sec after the stimulation period ended. In the remain-
ing test, the imminent void was initially suppressed; however, a
void occurred after 36 sec, that is, before the end of the 60 sec
stimulation period.
Sacral Nerve Stimulation
Once we had established the effectiveness of pelvic nerve stim-
ulation, we investigated whether similar effects could be pro-
duced by stimulating the sacral nerve root at S1. In each rat (6/6
tested), imminent voiding was suppressed by stimulation at S1,
initiated within 0.9–3.0 sec (mean 1.8  0.16 sec) of the onset of
the preceding steep rise in pressure, using stimulation parameters
that were optimal for inhibiting voiding when stimulating the pel-
vic nerve in that animal (1 or 3 kHz, 1 mA, Fig. 2b). Typically,
bladder pressure continued to rise after the stimulation onset,
reached a peak, and then reduced rapidly, stabilizing at a lower
level for the remainder of the 60 sec stimulation period or until a
void occurred (whichever was the shorter time) (Fig. 3b). Once
the void had taken place, bladder pressure returned to baseline.
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Table 1. Urodynamic Parameters of Spontaneous Voids Induced by Saline
Infusion (6 mL/h) for Each Rat. We Defined Baseline Pressure as the
Pressure in the Bladder Prior to Starting Infusion of Saline; Void Threshold
Was the Pressure at the Onset of the Sharp Rise in Pressure Signaling an
Imminent Void; Contraction Pressure Was Maximum Pressure-Threshold
Pressure.
Rat Intervoid
interval (sec)
Detrusor baseline
pressure (mmHg)
Void
threshold
(mmHg)
Detrusor
contraction
pressure
(mmHg)
1 184.3  14.0 8.7  0.1 15.9  0.6 7.5  0.2
2 81.3  13.5 7.9  0.3 11.0  0.3 7.0  0.3
3 86.0  14.0 7.9  0.4 13.9  0.7 7.9  0.7
4 108.2  7.3 8.0  0.3 17.1  0.5 9.0  1.0
5 214.8  16.3 6.1  0.2 16.1  0.5 5.9  0.4
6 193.9  51.9 6.7  0.1 19.1  1.1 4.6  0.4
Figure 2. a. Change in bladder pressure and abdominal electromyogram
during a spontaneous void. Urine drops channel indicates timing of drops of
urine exiting the urethra. b. Effect of stimulus frequency on inhibition of void-
ing during the first 30 s of stimulating the pelvic nerve and S1 root (six rats).
Voided volume during stimulation is plotted as number of urine drops
expelled expressed as a percentage of the mean of the previous three sponta-
neous voids (baseline). * p < 0.05 pelvic n.; $ p < 0.05 S1 compared to base-
line; Wilcoxon signed-rank test (ANOVA not possible due to incomplete data
set for all frequencies). c. Effects of stimulating pelvic nerve (i) and S1 root
(ii) during the filling phase in between voids. Data from the same rat using
the same stimulation parameters that inhibited voiding when applied at the
onset of an imminent void.
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In three of the rats, voiding was suppressed completely for the
entire 60 sec stimulation period, resuming 10, 76, and 262 sec,
respectively, after the stimulation ceased. On the other occasions
in the same experiment and in all tests carried out in the three
remaining rats, the imminent void was initially suppressed, how-
ever, a void occurred before the end of the stimulation period
(35–56 sec, mean 44.0  3.2 sec, after stimulus onset). Of the
three rats in which stimulation at S1 suppressed voiding
completely for the entire 60 sec stimulation period, the optimal
stimulation frequency to produce this effect was 1 kHz in two rats
and 3 kHz in the other one. For the three rats in which we were
able only to defer voiding, changing the stimulation frequency
did not improve the outcome.
Optimal Stimulation Parameters for S1 Stimulation
We chose initially to use stimulation parameters for sacral nerve
stimulation that we had found previously to be optimal for inhi-
biting voiding by stimulating the preganglionic pelvic nerve bun-
dle (8). However, we also tested the effect of stimulation over a
range of frequencies (0.5‑10 kHz). The range of stimulus frequen-
cies that was optimal for suppressing voiding using S1 stimulation
(1‑3 kHz) was the same as for the pelvic nerve (Fig. 2b). The effect
was intensity dependent. Stimulation at S1 using 0.75 mA (N = 2)
did not suppress voiding, whereas increasing the current to 2 mA
inhibited voiding effectively but produced significant movement
artifact (N = 3); we therefore restricted stimulation to 1 mA in fur-
ther tests.
Stimulation During the Filling Phase
No urine was ever expelled in response to stimulating either
the pelvic nerve or S1 root during the filling phase, when the
bladder was approximately half full. However, stimulation of
S1 at frequencies that suppressed voiding did evoke a tonic
increase in abdominal EMG activity, which lasted for the dura-
tion of the stimulation period (Fig. 2cii). There was also a small,
transient increase in bladder pressure (2.2  0.6 mmHg) at the
onset of the stimulation. In contrast, stimulating the pelvic
nerve at the same frequencies evoked only a transient increase
in abdominal EMG activity at the onset of the stimulation
(Fig 2ci), and a slightly larger, but transient, increase in bladder
pressure (11.1  3.6 mmHg).
Cardiovascular Effects Evoked by High Frequency Pelvic
Nerve or S1 Stimulation
Stimulating S1 at any of the frequencies tested (0.5‑10 kHz) for
their ability to suppress imminent voids produced only a very
small change in blood pressure (mean of maximum response in
each rat 5.2  0.9 mmHg). This contrasts with pelvic nerve stimu-
lation, which evoked an increase in blood pressure at the onset of
stimulation. Interestingly, the maximum effect (18.3  4.6 mmHg)
was evoked at the lowest frequency tested (500 Hz), which in
general was not effective in blocking voiding.
DISCUSSION
The present study was designed to compare the effectiveness
of high-frequency stimulation of the S1 root and the pelvic nerve
to inhibit voiding. As reported previously by us and by others,
continuous infusion of saline into the bladder evoked repeated
voiding (8,14,15). In addition, we observed contraction of the
external oblique musculature of the abdominal wall during void-
ing. This has also been described in conscious rats (16,17) and
may aid expulsion of urine by adding to the increase in intravesi-
cular pressure generated as the bladder contracts.
In the present study, 48% of the rats prepared for cystometry
voided reliably. This is rather lower than our past experience in
which around 70% of urethane-anesthetized rats developed reli-
able voiding (8). The lower success rate in the present study may
be linked to the more invasive surgery necessary to access both
the sacral root and pelvic nerve, which included the added steps
of closing the abdominal wall after exposing the bladder and pel-
vic nerve, turning the rat prone, and the further surgery to expose
the S1 vertebra.
The use of anesthesia in the present study is another possible
confound. However, voiding evoked during continuous cystome-
try under urethane anesthesia is similar to that seen in conscious
rats, differing principally with respect to the volume and fre-
quency of voids (9,18,19). Most importantly for the present inves-
tigation, the inhibitory effect of pelvic nerve stimulation is also
similar in anesthetized and conscious rats (8,9). Urethane is there-
fore not a confounding factor likely to bias the response to S1
stimulation. Nevertheless, it will be important in the future to
repeat the study in conscious, chronically instrumented animals.
High infusion rates (6 mL h−1 in our experiments), which are
many times the rate at which the bladder fills naturally via the
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Figure 3. a. Stimulating the pelvic nerve (gray panel) suppressed voiding. b. In the same rat, stimulation of the S1 root deferred the imminent void until just
before the end of the stimulation period.
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ureters, are used routinely during cystometry in rats for the con-
venience of evoking voids every few minutes (e.g., 8, 14, 15, 19).
In the present study, the infusion of saline into the bladder
continued throughout the 1 min period of nerve stimulation,
during which imminent voiding was suppressed. This continu-
ing filling of the bladder, beyond the threshold for voiding,
may pose a risk of myogenic damage due to overdistension of
the bladder while voiding was suppressed. However, in another
study on modulation of voiding, we continued to fill for up to
7 min while suppressing voiding by stimulation in the brain
and observed no ill effects (15), suggesting that the detrusor
had not been compromised. It is worth noting that a stimula-
tion paradigm that is able to suppress voiding when the stimu-
lus to void is above threshold, and continuing to increase
rapidly, is likely to be even more effective when tested during
more physiological filling rates.
The primary objective of the present study was to determine
whether stimulation of S1 could inhibit voiding and how this
compared with stimulation of the pelvic nerve. In agreement
with our previous study (8), in each animal tested (6/6 rats),
high-frequency stimulation of the pelvic nerve produced a rapid
onset and readily reversible suppression of voiding. Stimulation
at S1 also suppressed imminent voids in every rat. This repre-
sents a 100% success rate. However, in contrast to pelvic nerve
stimulation, which suppressed voiding completely for the whole
of the 60 sec stimulation period in every rat tested, stimulation
at S1 suppressed voiding for the entire 60 sec stimulation period
in 50% of animals. In the remainder, the imminent void was
suppressed initially, but a void occurred toward the end of the
stimulation period. At first sight, this suggests that stimulation at
S1 is less effective than stimulation of the pelvic nerve. However,
although pelvic nerve fibers project through the S1 root in
Wistar rats (10) and would be activated by stimulation at this
level, other fibers in the S1 root will also be activated, which
may evoke responses that conflict with the effects of pelvic
nerve stimulation. Another explanation for differential effects
may relate to the type of electrodes we used for stimulating the
pelvic nerve and S1 root (respectively, cuff on the pelvic nerve
vs. bipolar needle electrode on the S1 foramen). The larger
diameter of the S1 nerve trunk compared to the pelvic nerve,
the difference in dimensions of the stimulating electrodes, and
their proximity to the nerve bundle at the two stimulation sites
would mean that current density in the sacral nerve bundle
would be lower than for the pelvic nerve when identical currents
were applied. Our exploration of the effectiveness of S1 stimula-
tion at higher currents was limited by motor side effects. In
future studies, the use of a custom-designed electrode more
closely opposed to the sacral nerve root bundle should be able
to resolve this limitation of the present experiments. Even so,
this initial study does provide proof-of-concept for inhibiting
voiding “on demand” by stimulation at S1.
Stimulation of the S1 root at frequencies that blocked voiding
evoked a sustained, but low level, contraction of the abdominal
wall. While this is likely to reflect reflex activation of the abdomi-
nal musculature due to activation of S1 afferents from the uterus
and colon (20–22), another possibility is that it might represent a
viscerosomatic response to activation of nociceptive afferents
(23). The latter explanation seems unlikely however because nox-
ious colorectal distension under urethane anesthesia has been
shown to be accompanied by a depressor response (23), while in
the present study stimulation at S1 evoked a very small increase
in blood pressure and only in some tests. Nevertheless, it will be
important to test the behavioral responsiveness to S1 stimulation
in conscious rats, in order to resolve the question unequivocally.
Previous studies have demonstrated that low frequency (<20 Hz)
stimulation of S1 in rats and S2 in larger mammals can increase
bladder capacity and inhibit isovolumetric bladder contractions
(24–26). The superiority of dorsal vs. ventral root stimulation indi-
cated that the effect was mediated by activation of afferent fibers
(24,26). High-frequency (1‑3 kHz) stimulation of the pelvic nerve,
which suppresses integrated voiding is also thought to be due to
activation of afferent fibers (8). In the present study, stimulation at
the level of the S1 foramen would most likely engage these same
afferent fibers, although the stimulus would be less selective as
afferents from other sources converging at the S1 root would be
activated as well.
The mechanisms underlying the effectiveness of neuromodula-
tion strategies to control bladder function are not fully understood.
Recent thinking is that activation of afferents by low-frequency
stimulation results in a change in bladder perception threshold and
an increased bladder capacity, almost certainly mediated via a cen-
tral mechanism (27–29). The effectiveness of high-frequency stimu-
lation is also thought to be due to activation of afferent fibers,
albeit likely via engagement of a different central mechanism (8).
It has been proposed that stimulation of pelvic nerve afferents
at frequencies in the kHz range may impose an unphysiological
pattern of firing that leads to a functional occlusion of the central
voiding circuitry, thereby preventing a void from being gener-
ated (8).
Devices for sacral nerve stimulation currently in clinical use are
usually restricted to using continuously applied low (10’s of Hz)
frequencies, although a limited number of studies suggest that
preprogrammed or patient-operated schedules of intermittent
stimulation may also be effective (30,31). Novel stimulation para-
digms applied to the pelvic nerve using frequencies in the kHz
range developed by us (8,9) or using combinations of high and
low frequencies (32) have the potential to produce sophisticated
and flexible modulation to target different types of voiding dys-
function. The functional response to high-frequency stimulation
of the S1 root and pelvic nerve described in the present study
(total, immediate, and readily reversible suppression of imminent
voids) differs from the functional response (increase in bladder
capacity) produced by the low-frequency stimulation regimens in
clinical use.
CONCLUSION
The results of the present study provide proof-of-concept for
the development of high-frequency stimulation to suppress invol-
untary urinary voids “on demand” in humans. Although the distal
pelvic nerve and the sacral roots are both effective stimulation
sites, the sacral root provides the more accessible target. There is
also a considerable body of clinical experience in implantation of
stimulators at sacral level. For the individual with urinary urge
incontinence, the opportunity to activate their stimulator at the
onset of urge sensation and suppress imminent involuntary voids
would restore autonomy over their bladder emptying. As implant-
able sensor technology develops (33,34), it may become possible
to incorporate a stimulator into a device, which would detect
bladder fullness and/or sharp rises in bladder pressure and then
alert the individual to the need to empty their bladder while at
the same time activating the stimulator to suppress the imminent
void and prevent an incontinent episode. Such a “smart” device
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could have applications for those with impaired bladder sensa-
tion, for example, after spinal cord injury, as well as patients with
urinary urge incontinence.
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